Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Name: Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Published: 2017
License: Public Domain

Roswell Park Cancer Institute · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

acute myeloid leukemia in remission, adult acute lymphoblastic leukemia in complete remission, chronic myelogenous leukemia, bcr-abl1 positive in remission, chronic myelomonocytic leukemia in remission, graft versus host disease, hodgkin lymphoma, minimal residual disease, myelodysplastic syndrome, myeloproliferative neoplasm, non-hodgkin lymphoma, plasma cell myeloma, severe aplastic anemia

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 827319
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.